MIM
RXO icon

MetLife Investment Management’s RXO RXO Stock Holding History

MetLife Investment Management’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Buy
97,880
+8,445
+9% +$186K 0.01% 970
2026
Q1 		$1.31M Sell
89,435
-4,653
-5% -$68.3K 0.01% 1275
2025
Q4 		$1.19M Sell
94,088
-3,358
-3% -$49.5K 0.01% 1326
2025
Q3 		$1.5M Hold
97,446
– – 0.01% 1241
2025
Q2 		$1.53M Buy
97,446
+2,939
+3% +$44.6K 0.01% 1124
2025
Q1 		$1.81M Sell
94,507
-1,444
-2% -$31.6K 0.01% 1086
2024
Q4 		$2.29M Buy
95,951
+17,496
+22% +$488K 0.01% 970
2024
Q3 		$2.2M Buy
78,455
+10,993
+16% +$310K 0.01% 966
2024
Q2 		$1.76M Buy
67,462
+5,919
+10% +$123K 0.01% 1039
2024
Q1 		$1.35M Hold
61,543
– – 0.01% 1137
2023
Q4 		$1.43M Hold
61,543
– – 0.01% 1120
2023
Q3 		$1.21M Hold
61,543
– – 0.01% 1135
2023
Q2 		$1.4M Buy
61,543
+58,847
+2,183% +$1.19M 0.01% 1086
2023
Q1 		$53K Sell
2,696
-69,826
-96% -$1.34M ﹤0.01% 2716
2022
Q4 		$1.25M Buy
+72,522
New +$1.29M 0.01% 1102

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

MetLife Investment Management's RXO Position: Q2 2026 in Review

MetLife Investment Management increased its RXO (RXO) stake by 9.4% in Q2 2026, buying an estimated $186K and bringing the position to 97,880 shares worth $2.7M. The position accounts for 0.01% of the portfolio, ranked #970.

MetLife Investment Management first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • MetLife Investment Management held 97,880 shares of RXO worth $2.7M as of Q2 2026.
  • MetLife Investment Management bought 8,445 RXO shares in Q2 2026, an estimated $186K.
  • RXO made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #970 holding.
  • MetLife Investment Management first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.